SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D. C. 20549
FORM 8-K
CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): NOVEMBER 19, 2003
HALSEY DRUG CO., INC.
695 NORTH PERRYVILLE ROAD, ROCKFORD, ILLINOIS 61107
(815-399-2060)
Incorporated under the laws of Commission File Number I.R.S. Employer Identification Number
State of New York 1-10113 11-0853640
ITEM 12. RESULTS OF OPERATIONS AND FINANCIAL CONDITION
On November 19, 2003, Halsey Drug Co., Inc. (the "Company") issued a
press release disclosing the financial results for its third quarter ended
September 30, 2003 and the nine months ended September 30, 2003. A copy of the
Company's press release is attached as Exhibit 99.1 hereto.
ITEM 7. FINANCIAL STATEMENTS, PRO FORMA FINANCIAL INFORMATION AND EXHIBITS.
(B) EXHIBITS
EXHIBIT
NUMBER DESCRIPTION
------ -----------
99.1 Press Release dated November 19, 2003 Announcing Results
for Third Quarter ended September 30, 2003
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
HALSEY DRUG CO., INC.
By: /s/ Peter A. Clemens
------------------------------------
Peter A. Clemens
Vice President & Chief Financial
Officer
Date: November 19, 2003
3
EXHIBIT INDEX
EXHIBIT
NUMBER DESCRIPTION
------ -----------
99.1 Press Release dated November 19, 2003 Announcing Results
for Third Quarter ended September 30, 2003.
4